ClinSpec Diagnostics reaches funding target of £3.5m :

ClinSpec Diagnostics reaches funding target of £3.5m
5th March 2021
Glasgow-based ClinSpec Diagnostics has secured an additional £1.1m investment, reaching its round two funding target of £3.5m.
ClinSpec, a spin-out company from the University of Strathclyde’s Department of Pure and Applied Chemistry, is aiming to develop liquid biopsies for the early detection of cancer.
The new £1.1m investment from the latest funding round comes from a range of investors, including Norcliffe Capital Limited, the University of Strathclyde, Eos Advisory and the founders.
The first £2.4m was secured in 2020, with that funding round led by Mercia’s EIS Funds with Scottish Enterprise, SIS Ventures, Eos Advisory and the University of Strathclyde.

Related Keywords

Mark Hegarty , Norcliffe Capital , University Of Strathclyde , University Of Strathclyde Department Pure , Glasgow Based Clinspec Diagnostics , Applied Chemistry , Norcliffe Capital Limited , Neos Advisory , Scottish Enterprise , Clinspec Diagnostics , Liquid Biopsy , Cancer Detection , Funding Round , குறி ஹெகார்டி , பயன்படுத்தப்பட்டது வேதியியல் , ஸ்காட்டிஷ் நிறுவன , திரவ பயாப்ஸி , புற்றுநோய் கண்டறிதல் , நிதி சுற்று ,